Latest Earnings Results: Q3 '26
Estimated EPS
-$0.68
Reported EPS
-$0.64
Surprise
+5.59%
Estimated Rev
$21.5M
Reported Rev
$27.71M
Surprise
+28.89%
• Reported GAAP EPS of -$0.64 up 55.86% YoY • Reported revenue of $27.71M down -28.66% YoY • Ginkgo Bioworks reaffirmed expected total cash burn of ($150)--$125M in 2026; quantified revenue, margin, and earnings guidance was not provided in this outlook update.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$1.04 | -- | -- | N/A |
Q3 '26 | -$0.68 | -$0.64 | 5.59% | BEAT |
Q2 '26 | -$1.09 | -$0.75 | 31.19% | BEAT |
Q1 '26 | -$1.21 | -$1.39 | -14.77% | MISSED |
Q4 '25 | -$1.46 | -$1.41 | 3.09% | BEAT |